The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Toward a Therapeutic Approach

dc.contributor.authorKorf, Bruce
dc.contributor.authorAhmadian, Reza
dc.contributor.authorAllanson, Judith
dc.contributor.authorAoki, Yoko
dc.contributor.authorBakker, Annette
dc.contributor.authorBurkitt Wright, Emma
dc.contributor.authorDenger, Brian
dc.contributor.authorElgersma, Ype
dc.contributor.authorGelb, Bruce D.
dc.contributor.authorGripp, Karen W.
dc.contributor.authorKerr, Bronwyn
dc.contributor.authorKontaridis, Maria
dc.contributor.authorLázaro García, Conxi
dc.contributor.authorLinardic, Corinne
dc.contributor.authorLozano Rubí, Raimundo
dc.contributor.authorMacRae, Calum A.
dc.contributor.authorMessiaen, Ludwine M.
dc.contributor.authorMulero Navarro, Sonia
dc.contributor.authorNeel, Benjamin
dc.contributor.authorPlotkin, Scott
dc.contributor.authorRauen, Katherine A.
dc.contributor.authorRoberts, Amy
dc.contributor.authorSilva, Alcino J.
dc.contributor.authorSittampalam, Sitta G.
dc.contributor.authorZhang, Chao
dc.contributor.authorSchoyer, Lisa
dc.date.accessioned2018-11-30T13:14:44Z
dc.date.available2018-11-30T13:14:44Z
dc.date.issued2015-08
dc.date.updated2018-07-25T07:58:40Z
dc.description.abstractThe Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Towards a Therapeutic Approach was held at the Renaissance Orlando at SeaWorld Hotel (August 2-4, 2013). Seventy-one physicians and scientists attended the meeting, and parallel meetings were held by patient advocacy groups (CFC International, Costello Syndrome Family Network, NF Network and Noonan Syndrome Foundation). Parent and patient advocates opened the meeting with a panel discussion to set the stage regarding their hopes and expectations for therapeutic advances. In keeping with the theme on therapeutic development, the sessions followed a progression from description of the phenotype and definition of therapeutic endpoints, to definition of genomic changes, to identification of therapeutic targets in the RAS/MAPK pathway, to preclinical drug development and testing, to clinical trials. These proceedings will review the major points of discussion.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid25900621
dc.identifier.urihttps://hdl.handle.net/2445/126649
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1002/ajmg.a.37089
dc.relation.ispartofAmerican Journal of Medical Genetics Part A, 2015, vol. 167, num.8, p. 1741-1746
dc.relation.urihttps://doi.org/10.1002/ajmg.a.37089
dc.rights(c) Wiley, 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationNeurofibromatosi
dc.subject.classificationSíndrome de Noonan
dc.subject.otherNeurofibromatosis
dc.subject.otherNoonan Syndrome
dc.titleThe Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Toward a Therapeutic Approach
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
KorfB.pdf
Mida:
88.75 KB
Format:
Adobe Portable Document Format